Impact of COVID-19 on Global Elimination of Viral Hepatitis: The US Perspective

Date: Thursday, October 22, 2020
Presenters: David L, Thomas, MD, MPH | Don C Des Jarlais, PhD | Natasha Martin, DPhil

On October 22, AASLD hosted a webinar where the discussion focused on COVID-19's major impact on the goal of global elimination of viral hepatitis.

This webinar:

Discusses the impact of SARs-CoV-2 on the viral care cascade

Identifies services disrupted by COVID-19 that will impact the future of HCV elimination in the US

Outlines innovative alternatives to minimize the influence of COVID19 on viral hepatitis

Download the slide deck [PDF].